BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31327258)

  • 21. Association of Reversal of Renin Suppression With Long-Term Renal Outcome in Medically Treated Primary Aldosteronism.
    Katsuragawa S; Goto A; Shinoda S; Inoue K; Nakai K; Saito J; Nishikawa T; Tsurutani Y
    Hypertension; 2023 Sep; 80(9):1909-1920. PubMed ID: 37449450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
    Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Worsening of lipid metabolism after successful treatment of primary aldosteronism.
    Adolf C; Asbach E; Dietz AS; Lang K; Hahner S; Quinkler M; Rump LC; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Reincke M
    Endocrine; 2016 Oct; 54(1):198-205. PubMed ID: 27179655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-stratified comparison of clinical outcomes between medical and surgical treatments in patients with unilateral primary aldosteronism.
    Nakamaru R; Yamamoto K; Akasaka H; Rakugi H; Kurihara I; Yoneda T; Ichijo T; Katabami T; Tsuiki M; Wada N; Yamada T; Kobayashi H; Tamura K; Ogawa Y; Kawashima J; Inagaki N; Fujita M; Watanabe M; Kamemura K; Okamura S; Tanabe A; Naruse M;
    Sci Rep; 2021 Mar; 11(1):6925. PubMed ID: 33767283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparisons of risk factors for post-treatment renal dysfunction between the two major subtypes of primary aldosteronism.
    Watanabe D; Morimoto S; Morishima N; Ichihara A
    Endocrine; 2024 Apr; 84(1):245-252. PubMed ID: 38087188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgery decreases the long-term incident stroke risk in patients with primary aldosteronism.
    Chang YH; Chung SD; Wu CH; Chueh JS; Chen L; Lin PC; Lin YH; Huang KH; Wu VC; Chu TS;
    Surgery; 2020 Feb; 167(2):367-377. PubMed ID: 31676114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic kidney disease score for predicting postoperative masked renal insufficiency in patients with primary aldosteronism.
    Tanase-Nakao K; Naruse M; Nanba K; Tsuiki M; Tagami T; Usui T; Okuno H; Shimatsu A; Hashimoto S; Katabami T; Ogo A; Okumura A; Umakoshi H; Suzuki T
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):665-70. PubMed ID: 24821606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal Function Evolution and Hypoaldosteronism Risk After Unilateral Adrenalectomy for Primary Aldosteronism.
    Queiroz NL; Stumpf MAM; Souza VCM; Maciel AAW; Fagundes GFC; Okubo J; Srougi V; Tanno FY; Chambo JL; Pereira MAA; Pio-Abreu A; Bortolotto LA; Latronico AC; Barisson Villares Fragoso MC; Drager LF; Mendonça BB; Almeida MQ
    Horm Metab Res; 2024 May; 56(5):350-357. PubMed ID: 38040032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of achieved blood pressure after treatment for primary aldosteronism with long-term kidney function.
    Haze T; Yano Y; Hatano Y; Tamura K; Kurihara I; Kobayashi H; Tsuiki M; Ichijo T; Wada N; Katabami T; Yamamoto K; Okamura S; Kai T; Izawa S; Yoshikawa Y; Yamada M; Chiba Y; Tanabe A; Naruse M;
    J Hum Hypertens; 2022 Oct; 36(10):904-910. PubMed ID: 34462544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness.
    Holaj R; Rosa J; Zelinka T; Štrauch B; Petrák O; Indra T; Šomlóová Z; Michalský D; Novák K; Wichterle D; Widimský J
    J Hypertens; 2015 Apr; 33(4):874-82; discussion 882. PubMed ID: 25490707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of primary aldosteronism on renal function in patients with type 2 diabetes.
    Katsuragawa S; Tsurutani Y; Takiguchi T; Saito J; Nishikawa T
    J Diabetes Investig; 2021 Feb; 12(2):217-225. PubMed ID: 32583599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years.
    Wu VC; Chueh SJ; Chen L; Chang CH; Hu YH; Lin YH; Wu KD; Yang WS;
    J Hypertens; 2017 Aug; 35(8):1698-1708. PubMed ID: 28661412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kidney impairment in primary aldosteronism.
    Wu VC; Yang SY; Lin JW; Cheng BW; Kuo CC; Tsai CT; Chu TS; Huang KH; Wang SM; Lin YH; Chiang CK; Chang HW; Lin CY; Lin LY; Chiu JS; Hu FC; Chueh SC; Ho YL; Liu KL; Lin SL; Yen RF; Wu KD;
    Clin Chim Acta; 2011 Jul; 412(15-16):1319-25. PubMed ID: 21345337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors Predicting Long-term Estimated Glomerular Filtration Rate Decrease, a Reliable Indicator of Renal Function After Adrenalectomy in Primary Aldosteronism.
    He Q; Tan Z; Liu Y; Zhou L
    Endocr Pract; 2023 Mar; 29(3):199-205. PubMed ID: 36563786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism.
    Satoh M; Maruhashi T; Yoshida Y; Shibata H
    Hypertens Res; 2019 Jun; 42(6):817-824. PubMed ID: 30948836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of Alternative Therapy with Hydrocortisone in the Postoperative Management of Severe Primary Aldosteronism.
    Asakawa M; Takagi N; Hamada D; Yamasaki Y; Takaku Y; Kawada M; Murata T; Katsuta H
    Intern Med; 2023 Oct; 62(20):2981-2988. PubMed ID: 36858518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of contralateral suppression on kidney function after surgery in patients with primary aldosteronism.
    Voss N; Mørup S; Clausen C; Feltoft CL; Jepsen JV; Hornum M; Andreassen M; Krogh J
    Clin Endocrinol (Oxf); 2023 Mar; 98(3):306-314. PubMed ID: 36263597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperkalemia in both surgically and medically treated patients with primary aldosteronism.
    Wada N; Shibayama Y; Umakoshi H; Ichijo T; Fujii Y; Kamemura K; Kai T; Sakamoto R; Ogo A; Matsuda Y; Fukuoka T; Tsuiki M; Suzuki T; Naruse M
    J Hum Hypertens; 2017 Oct; 31(10):627-632. PubMed ID: 28540931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aldosterone level after saline infusion test could predict clinical outcome in primary aldosteronism after adrenalectomy.
    Chan CK; Kim JH; Chueh E; Chang CC; Lin YF; Lai TS; Huang KH; Lin YH; Wu VC;
    Surgery; 2019 Sep; 166(3):362-368. PubMed ID: 31208863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.